Health

Common Steroid Cuts Risk of Death Among Sickest COVID-19 Patients: Study

A common steroid drug used to treat conditions from altitude sickness to eye inflammation has now been shown to reduce deaths in the sickest patients hospitalized with COVID-19, according to British scientists.

Researchers added that the drug, called dexamethasone, has been shown to have had a positive impact by a third in death rates aligned with the coronavirus.

Researchers at the University of Oxford in the U.K. compared outcomes of 2,104 hospitalized patients who received the steroid with 4,321 patients who did not, finding that deaths were reduced by about a third in those patients who were sick enough to require mechanical ventilation, and by about 20% among patients who had trouble breathing but had not been put on a ventilator.

However, the drug did not appear to help patients who did not require oxygen.

Dr. Ashish Jha, director of the Harvard Global Health Institute, lamented in a tweet Tuesday: “It is now a feature of this pandemic that most findings made public via press release with little data to provide context.”

But, Jha added, “if this holds up — this is very good news indeed!”

Tags
Show More

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *


By submitting this form, you are consenting to receive marketing emails from: Washington Informer Newspaper, 3117 Martin Luther King Jr. Ave SE, Washington, DC, 20032, http://www.washingtoninformer.com. You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact

Back to top button

My News Matters to me - Washington Informer Donations

Be a Part of The Washington Informer Legacy

A donation of your choice empowers our journalists to continue the work to better inform, educate and empower you through technology and resources that you use.

Click Here Today to Support Black Press and be a part of the Legacy!

Subscribe today for free and be the first to have news and information delivered directly to your inbox.


By submitting this form, you are consenting to receive marketing emails from: Washington Informer Newspaper, 3117 Martin Luther King Jr. Ave SE, Washington, DC, 20032, http://www.washingtoninformer.com. You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact
Close

Adblock Detected

Please consider supporting us by disabling your ad blocker